← Browse by Condition
Medical Condition
sarcoma
Total Trials
21
Recruiting Now
21
Trial Phases
Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for sarcoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — sarcoma Clinical Trials
How many clinical trials are currently recruiting for sarcoma?
ClinicalMetric currently tracks 21 actively recruiting clinical trials for sarcoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 21. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for sarcoma?
sarcoma research spans Phase 1 (4 trials), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a sarcoma clinical trial?
Eligibility criteria for sarcoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 4
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04758325
Recruiting
Enrollment
3,000 pts
Location
Germany
Sponsor
Prof. Dr. Richard F Schlenk
NCT04498767
Recruiting
Enrollment
200 pts
Location
Belgium, France, Ger...
Sponsor
European Organisation for Rese...
NCT07134192
Recruiting
Enrollment
90 pts
Location
Denmark
Sponsor
University of Aarhus
NCT06637007 Phase 2
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Shanxi Province Cancer Hospita...
NCT05830123 Phase 2
Recruiting
Enrollment
170 pts
Location
China
Sponsor
Hansoh BioMedical R&D Company
NCT06942143 Phase 1
Recruiting
Enrollment
15 pts
Location
China
Sponsor
Guangzhou FineImmune Biotechno...
NCT04122872
Recruiting
Enrollment
9,000 pts
Location
Germany
Sponsor
Institut für Klinische Krebsfo...
NCT06644755 Phase 1
Recruiting
Enrollment
150 pts
Location
United States, Belgi...
Sponsor
Daiichi Sankyo
NCT04354064
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
Washington University School o...
NCT04461171
Recruiting
Enrollment
120 pts
Location
United States
Sponsor
Joshua Lawrenz
NCT06129903
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06242470 Phase 1
Recruiting
Enrollment
250 pts
Location
United States, Austr...
Sponsor
MacroGenics
NCT06193369
Recruiting
Enrollment
138 pts
Location
Canada
Sponsor
University Health Network, Tor...
NCT05253131 Phase 2
Recruiting
Enrollment
41 pts
Location
United States
Sponsor
University of Alabama at Birmi...
NCT06580002 Phase 2
Recruiting
Enrollment
75 pts
Location
United States
Sponsor
University of California, Irvi...
NCT01109394
Recruiting
Enrollment
6,035 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06910657 Phase 1
Recruiting
Enrollment
78 pts
Location
United States, Austr...
Sponsor
ViroMissile, Inc.
NCT03978039
Recruiting
Enrollment
150,000 pts
Location
France
Sponsor
Institut Bergonié
NCT04458792
Recruiting
Enrollment
450 pts
Location
France
Sponsor
Institut du Cancer de Montpell...
NCT06805773
Recruiting
Enrollment
100 pts
Location
Canada
Sponsor
Mount Sinai Hospital, Canada
NCT07552467
Recruiting
Enrollment
26 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology